| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |